Cell and gene therapies have effectively treated complex indications such as leukaemia. Despite their proven results, the high production cost and lengthy manufacturing time prevent all patients from benefitting from these remarkable technologies.

ImmTune Therapies is building a platform that allows for the in-patient generation of cell and gene therapies, radically increasing the potency and reach of these therapies to all the patients who need them by using novel delivery vectors.

Dr Bakul Gupta talks about her story as a founder and how she co-founded ImmTune with Dr George Tetley.